DGX vs GH
Quest Diagnostics Incorporated Common Stock · Guardant Health, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | DGX | GH |
|---|---|---|
| Price | $235.22 | $144.07 |
| Market Cap | $26.04B | $19.10B |
| P/E | 26.25 | — |
| P/B | 3.53 | — |
| P/S | 2.36 | 19.45 |
| ROE | 13.5% | — |
| Net Margin | 9.0% | -42.4% |
| Gross Margin | 32.9% | — |
| Revenue Growth | 11.8% | 32.9% |
| Dividend Yield | 0.77% | — |
| EPS | $8.96 | -$3.14 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.